VITALE, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 16.272
EU - Europa 7.597
AS - Asia 2.914
SA - Sud America 639
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 15
Totale 27.535
Nazione #
US - Stati Uniti d'America 16.207
RU - Federazione Russa 2.444
UA - Ucraina 1.529
CN - Cina 1.126
VN - Vietnam 886
GB - Regno Unito 744
IT - Italia 676
SE - Svezia 674
SG - Singapore 640
DE - Germania 634
BR - Brasile 556
FR - Francia 494
FI - Finlandia 142
HK - Hong Kong 69
NL - Olanda 69
PL - Polonia 50
EU - Europa 39
AR - Argentina 36
IN - India 35
CA - Canada 34
JP - Giappone 33
IE - Irlanda 27
BE - Belgio 19
MX - Messico 19
ZA - Sudafrica 19
AT - Austria 17
BD - Bangladesh 17
IQ - Iraq 16
ES - Italia 15
EC - Ecuador 13
MA - Marocco 13
AU - Australia 12
ID - Indonesia 11
TR - Turchia 11
PK - Pakistan 10
TN - Tunisia 7
VE - Venezuela 7
AZ - Azerbaigian 6
CL - Cile 6
CZ - Repubblica Ceca 6
GR - Grecia 6
PT - Portogallo 6
PY - Paraguay 6
SA - Arabia Saudita 6
BG - Bulgaria 5
CO - Colombia 5
ET - Etiopia 5
KR - Corea 5
LU - Lussemburgo 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
IR - Iran 4
KZ - Kazakistan 4
LT - Lituania 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
AL - Albania 3
DZ - Algeria 3
HR - Croazia 3
LB - Libano 3
PE - Perù 3
RS - Serbia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SO - Somalia 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
Totale 27.520
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.679
Ann Arbor 1.318
Dallas 1.106
Wilmington 1.054
Ashburn 959
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 689
Dearborn 535
Nyköping 441
Jacksonville 427
Shenzhen 395
Southend 392
Moscow 379
Beijing 306
Boardman 283
Singapore 241
Lawrence 152
Princeton 151
Ogden 108
Shanghai 106
New York 98
The Dalles 93
Naples 75
San Diego 74
Grafing 69
Hong Kong 68
Los Angeles 68
Norwalk 63
Düsseldorf 62
London 54
Des Moines 49
Groningen 49
Rome 44
Yubileyny 44
Munich 43
Ho Chi Minh City 41
São Paulo 40
Falls Church 39
Chicago 37
Nanjing 36
Kraków 34
Jinan 31
Santa Clara 29
Hanoi 27
Columbus 26
Dublin 26
Bergamo 22
Shenyang 22
Rio de Janeiro 21
Milan 20
Hefei 19
Napoli 19
Tokyo 19
Brussels 18
Nanchang 18
Edinburgh 17
Toledo 16
Auburn Hills 15
Redwood City 15
Boston 14
Bremen 14
Kunming 14
Belo Horizonte 13
Helsinki 13
Salt Lake City 13
Warsaw 13
Washington 13
Curitiba 12
Frankfurt am Main 12
Kilburn 12
Vienna 12
Amsterdam 11
Florence 11
Montreal 11
Stockholm 11
Guangzhou 10
Lauterbourg 10
New Bedfont 10
Zhengzhou 10
Brasília 9
Tampa 9
Tappahannock 9
Toronto 9
Bari 8
Brooklyn 8
Changsha 8
Guayaquil 8
Hangzhou 8
Hebei 8
Matawan 8
Miami 8
Ningbo 8
Nürnberg 8
Wandsworth 8
Atlanta 7
Cape Town 7
Totale 19.158
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 612
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 292
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 287
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 286
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 271
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 262
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 259
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 258
Abnormal eating behaviors in progressive supranuclear palsy 254
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 253
Cognitive and affective theory of mind in patients with essential tremor 252
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 245
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 245
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 242
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 234
Affective theory of mind in patients with Parkinson's disease: comment 233
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 229
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 227
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 226
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 226
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 226
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 225
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 223
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 222
Impact of cognitive tasks on kinematic gait parameters in FTD patients 221
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 221
Apoptotic mechanisms in mutant LRRK2-mediated cell death 218
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 215
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 215
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 215
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 213
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 211
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 210
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 208
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 207
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 207
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 206
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 206
Pathological gambling in Parkinson's disease. A comprehensive review 205
Gender and non motor fluctuations in Parkinson's disease: a prospective study 205
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 204
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 203
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 202
How does smoking affect olfaction in Parkinson's disease? 202
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 202
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 198
The "eye of the tiger" sign in pure akinesia with gait freezing 197
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 196
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 195
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 194
Season of birth and Parkinson's disease: possible relationship? 194
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 193
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 193
Electrophysiological comparison between males and females in HNPP 192
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 192
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 192
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 191
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 190
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 190
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 188
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 187
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 186
Gender and non motor fluctuations in Parkinson's disease: A prospective study 186
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 185
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 184
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 184
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 182
Early MRI findings in Acquired hepatocerebral degeneration 182
The closing-in phenomenon in Parkinson's disease 182
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 182
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 181
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 180
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 180
A (single case) rehabilitation program based on cueing for freezing of speech 180
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 179
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 178
Uric acid relates to dopamine transporter availability in Parkinson's disease 178
Normative data for the Montreal Cognitive Assessment in an Italian population sample 177
Linkage exclusion in Italian families with hereditary essential tremor 175
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 175
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 175
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 175
Hemi-Restless Legs Syndrome induced by Clebopride 172
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 171
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 170
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 170
The relationship between cerebral vascular disease and parkinsonism: the VADO study 170
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 169
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 168
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 167
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 166
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 166
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 163
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 163
Using gait analysis' parameters to classify Parkinsonism: A data mining approach 162
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 160
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 160
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study. 160
Ping-pong gaze: Sherrington would not have done it better 159
Cognitive correlates of “pure apathy” in Parkinson's disease 158
Totale 20.527
Categoria #
all - tutte 111.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.511 0 0 0 187 426 105 337 39 148 241 136 892
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.479 61 360 26 109 96 401 1.121 1.358 336 238 206 167
2025/20262.221 377 863 793 188 0 0 0 0 0 0 0 0
Totale 27.826